Jordan Montgomery, a seasoned left-handed pitcher, is heading back to the Texas Rangers, the team he helped bring to World Series glory. But this time, it's a different story. The Rangers are taking a chance on a pitcher recovering from his second elbow reconstruction surgery.
On February 11, 2026, ESPN broke the news of Montgomery's one-year deal worth $1.25 million, with the potential for more based on performance. This reunion comes after a rollercoaster journey for the 33-year-old.
Traded to the Rangers in 2023, Montgomery delivered a stellar performance, including a crucial win in the AL Championship Series Game 7. However, his free agency led him to the Arizona Diamondbacks, where he struggled with injuries and inconsistent pitching. The $25 million contract he signed there sparked public backlash from the team owner, Ken Kendrick, especially after Montgomery's $22.5 million option for 2025 and subsequent surgery.
And this is where it gets intriguing: Montgomery has a history of bouncing back. He underwent Tommy John surgery in 2018 but still managed a solid career record. With eight big league seasons under his belt, including stints with the Yankees, Cardinals, Rangers, and Diamondbacks, he boasts a 46-41 record and a 4.03 ERA.
Is this Rangers deal a calculated risk or a potential comeback story? Only time will tell if Montgomery can reclaim his form and help the Rangers repeat their championship success. What do you think? Is this a smart move for the Rangers, or is it too risky? Share your thoughts in the comments!
